AU2025271141A1 — Therapeutic compounds useful for the prophylactic or therapeutic treatment of an HIV virus infection
Assigned to Gilead Sciences Inc · Expires 2025-12-18 · 0y expired
What this patent protects
The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): (Ia) (Ib) (IIa) F F F F F N NF ZI H F N CI O ZI H N N S N-N O F O S F FII O F, F F F F N NF F ZI H N CI O H N N S N-N O F O S F F O F F F F N NF ZI HF N CI O N ZI H N S N-N O O F O 11IS F "O…
USPTO Abstract
The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): (Ia) (Ib) (IIa) F F F F F N NF ZI H F N CI O ZI H N N S N-N O F O S F FII O F, F F F F N NF F ZI H N CI O H N N S N-N O F O S F F O F F F F N NF ZI HF N CI O N ZI H N S N-N O O F O 11IS F "O 20 25 27 11 41 21 N ov 2 02 5 N o v 2 0 2 5 F , F F F F N N 2 0 2 5 2 7 1 1 4 1 2 1 F F O N S N - N O F O S F F F F F F N N F F C I O H N N - N S O F O S F F F , F F F N F N F O N N - N S O F O "I S F H:\Interwoven\NRPortbl\DCC\VZS\20024752_1.docx-3/26/2020 (IIb) which are useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus. H:\Interwoven\NRPortbIDCC\VZS\20024752_1.docx-3/26/2020. F F F F NF F ZI H N CI O ZI H N N N-N S O F O /S F O== 20 25 27 11 41 21 N ov 2 02 5 F N o v 2 0 2 5 F F F N F F C I O N N - N S 2 0 2 5 2 7 1 1 4 1 2 1 F O S F
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.